It has been proposed that the anti-cancer effects of sigma-2 ligands might depend both on the sigma-2 ligand used and on the cell type, they involve caspase-dependent and -independent apoptosis, Ca2+ overload, ROS generation, lysosomal membrane permeabilization (LMP), and autophagy [92,93,94,95]. This evidence concerns the gene AP2S1 and cancer.